Denial Of Dismissal Bid In Pharmaceutical Company's Stock-Drop Suit Upheld
NEW YORK — A biopharmaceutical company and three of its senior officers have failed to sufficiently show that a federal judge in New York erred in denying their motion to dismiss...To view the full article, register now.
Already a subscriber? Click here to view full article